To increase transgene expression in the liver, electric pulses were applied to the left lateral lobe after intravenous injection of naked plasmid DNA (pDNA) or pDNA/liver targeting vector complex prepared with galactosylated poly(L-lysine) or galactosylated polyethyleneimine. Electroporation (250 V/cm, 5 ms/pulse, 12 pulses, 4 Hz) after naked pDNA injection dramatically increased the expression up to 200 000-fold; the expression level obtained was significantly greater than that achieved by the combination of pDNA/vector complex and electroporation. We clearly demonstrated that the expression was dependent on the plasma concentration of pDNA at the time when the electric pulses were applied. Separation of liver cells revealed that the distribution of naked pDNA as well as transgene expression was largely selective to hepatocytes in the electroporated lobe. The number of cells expressing transgene product using vascularly administered naked pDNA followed by electroporation was significantly (Po0.01) greater and more widespread than that obtained by local injection of naked pDNA. These results indicate that the application of in vivo electroporation to vascularly administered naked pDNA is a useful gene transfer approach to a large number of hepatocytes. Gene Therapy (2005) 12, 607-616.
Introduction
The success of in vivo gene therapy relies on the development of vectors that can selectively and effectively deliver a therapeutic gene to the target with minimal toxicity. Nonviral vectors such as naked plasmid DNA (pDNA) and its complex with a cationic vector, with or without a specific ligand, has advantages over viral vectors in terms of the simplicity of use, ease of large-scale production and lack of a specific immune response. 1 However, the low efficiency of transgene expression needs to be improved. We have developed various delivery systems for pDNA, incorporating galactose 2, 3 or mannose 4 to achieve cell-specific targeting to hepatocytes or liver nonparenchymal cells (NPC), respectively. These vectors were highly effective in delivering pDNA to the cells, but the transfection efficiency still needs to be improved.
A major barrier for successful in vivo gene transfer is the poor membrane permeability of pDNA as well as its lysosomal degradation within cells after entrance via endocytosis. Recently, various physical approaches such as electroporation, 5 sonoporation, 6 and hydrodynamic or hydrostatic pressure by large-volume injection 7, 8 have been developed for improving transgene expression by nonviral vectors. Among these approaches, in vivo electroporation, which is suggested to transiently create pores on cell membranes 9 and has been tested in clinical trials for cancer chemotherapy, 10, 11 has been extensively studied as a method to increase transgene expression by naked pDNA after local injection into the interstitial spaces of tissues. In vivo electroporation has been applied to various tissues including skin, 5 liver, 12,13 melanoma, 14 and muscle. 15 Generally speaking, electroporation increases transgene expression up to 1000-fold compared with that obtained with simple naked pDNA injection. However, the application of in vivo electroporation has been limited to locally injected pDNA, where the distribution of transgene-expressing cells is limited to a narrow area around the injection site. 16 Although the application of electric pulses to locally injected pDNA can increase the area of those cells, the spread is still limited due to the huge size of pDNA.
Vascularly administered pDNA can be distributed to a greater number of cells than locally injected pDNA. Therefore, the application of electroporation to vascularly administered pDNA could achieve transgene expression in a large target cell population. Gene therapy for the deficiency of an intracellular enzyme or structural protein requires functional restoration at the cell level, so the number of cells producing the transgene would be a major factor determining the therapeutic efficacy of the gene transfer approach. Although the application of electroporation after systemic administration of pDNA can be a promising technique to achieve this, it has received little attention so far. Recently, Liu and Huang 17 published a report on electroporation-mediated gene transfer to the liver after intravenous injection of naked pDNA. They found that electroporation combined with intravenous naked pDNA can be a good method of achieving gene transfer to a larger number of liver cells compared with locally injected pDNA. However, the characteristics of gene transfer and its underlying mechanism need to be investigated to optimize this technique, in which electroporation is applied to a tissue after vascularly administered pDNA. Due to its strong negative charge, naked pDNA is rapidly taken up by the liver NPC after intravenous injection, 18, 19 which results in no significant transgene expression in the organ. This uptake rapidly reduces the concentration of pDNA within the circulation. Although the results obtained by Liu and Huang 17 suggest that the distribution of pDNA would be altered by electroporation, little is known about the tissue distribution of pDNA. Targeted delivery of pDNA to hepatocytes can be achieved by galactosylated vectors, but the combined use of targeted delivery of pDNA using vectors and electroporation has not been examined so far.
We hypothesized that the application of electric pulses alters the distribution of pDNA at the site of electroporation. The liver is composed of various types of cells including hepatocytes, sinusoidal endothelial cells and Kupffer cells, and, in many genetic deficiencies such as ornithine transcarbamylase deficiency, hepatocytes can be the target of gene transfer. Therefore, we tried to achieve efficient gene transfer to hepatocytes by applying electroporation to intravenously administered pDNA. We injected pDNA into the tail vein of mice in the free form (naked pDNA) or in the complex form with a hepatocytetargeted vector: galactosylated poly(L-lysine) (Gal-PLL) 20 or galactosylated polyethyleneimine (Gal-PEI). 3 First, the effect of electroporation was examined on the whole-body distribution of naked pDNA and pDNA/Gal-PLL using 32 P-labeled pDNA. Then transgene expression in the liver was evaluated after administering intravenous pDNA or its complex followed by electroporation onto the liver. As naked pDNA showed the greatest transgene expression among the vectors examined, the characteristics of the expression by naked pDNA with electroporation were investigated in detail in terms of the distribution of pDNA and transfected cells within the electroporated lobe. We report here that intravenous naked pDNA injection followed by hepatic electroporation is a good way of achieving selective gene transfer to a number of hepatocytes with a higher transfection efficiency than that offered by vector-targeted gene transfer. Hepatocytes are found to be more susceptible to the effects of electroporation than other liver NPC, and the delivery of pDNA and transgene expression are selectively improved in hepatocytes by electroporation.
Results
Effect of electroporation on pharmacokinetics of pDNA and its complex After intravenous injection, 32 P-pDNA is preferentially taken up by liver NPC, 18, 19 whereas a large fraction of 32 P-pDNA/Gal-PLL is delivered to hepatocytes through asialoglycoprotein receptor-mediated endocytosis. 20 Without electroporation, both naked 32 P-pDNA and 32 P-pDNA/Gal-PLL showed similar pharmacokinetic profiles to those reported previously; 32 P-radioactivity quickly disappeared from the blood circulation and accumulated in the liver (Figures 1 and 2 ). When naked 32 P-pDNA was injected, the radioactivity in the liver quickly decreased with time (Figure 1 ), reflecting its degradation by the organ. A set of electric pulses (250 V/cm, 5 ms/pulse, 12 pulses, 4 Hz) was applied to the left lateral lobe of the liver at 30 s after intravenous injection of either naked Transgene expression was detected at 6 h after injection of 25 mg pDNA or its complex in the following experiments. The electroporation parameters were fixed as follows unless otherwise indicated: electric field, 250 V/cm; duration of each pulse, 5 ms; number of pulses, 12; frequency of pulses, 4 Hz; timing of pulses, 30 s after injection; site of electroporation, the left lateral lobe. No significant transgene expression was detected in the liver after intravenous injection of naked pDNA ( Figure 3 ). pDNA/Gal-PLL or pDNA/Gal-PEI complex showed detectable transgene expression in the liver.
However, the expression level obtained was not very high, probably due to the small dose of pDNA injected. The application of electric pulses increased the expression in the electroporated lobe of the liver against any vector used (Figure 3) . However, the enhancement ratio and the final level of transgene expression varied among the vectors. Naked pDNA showed the greatest enhancement ratio in transgene expression and the greatest expression level. The expression in the electroporated lobe increased up to 200 000-fold. The level of expression (about 2 Â 10 6 RLU/mg protein) was about 100-fold greater than that obtained after the injection of pDNA complex followed by electroporation.
To confirm the effect of electroporation on the receptor-mediated gene transfer, transgene expression by naked pDNA or pDNA/Gal-PLL was examined in HepG2 cells, a human hepatoma cell line expressing asialoglycoprotein receptors. Again, electroporation increased the expression to 4500-fold for naked pDNA and nine-fold for pDNA/Gal-PLL (data not shown), suggesting that the free form of pDNA is more effective than its complexed form for transgene expression once it enters into the cytoplasm of cells.
Effect of strength of electric field on transgene expression by vascular naked pDNA Figure 4 shows the transgene expression in the electroporated lobe and other lobes after intravenous injection of naked pDNA followed by electroporation with various electric fields from 50 to 500 V/cm. At any w Statistically significant difference between naked pDNA and all other groups (Po0.001).
Hepatocyte-targeted gene transfer by vascular pDNA M Sakai et al electric field examined, high transgene expression was obtained in the electroporated lobe, with a peak value at 250 V/cm. The expression in the nonelectroporated lobes was greater than that in the mouse liver receiving no electroporation shown in Figure 3 . These results suggest that the electric pulses applied to the left lateral lobe of the liver have some influence on transgene expression in other lobes. However, there was no significant transgene expression in other organs such as the kidney, spleen, lung and heart (o100 RLU/mg protein; data not shown).
Glutamic pyruvic transferase (GPT) activity in plasma rose slightly as the electric field of the pulses increased ( Figure 5 ). However, the activity was still low even at the highest electric field of 500 V/cm. The liver surface receiving the pulses did not show any significant changes following electroporation (data not shown).
Correlation between transgene expression and plasma concentration of pDNA Figure 6 shows the effect of the time interval between the intravenous injection of naked pDNA and electroporation on transgene expression in the electroporated lobe. Transgene expression decreased with the interval, and became undetectable when electric pulses were applied with an interval of 20 min or longer. GPT activity in mouse plasma after injection of naked pDNA followed by electroporation. Naked pDNA was injected into the tail vein at a dose of 25 mg/mouse, and electric pulses (50-500 V/cm, 5 ms/pulse, 12 pulses, 4 Hz) were applied to the left lateral lobe of the liver at 30 s after injection. Results are expressed as the mean7s.d. of at least three mice. *Statistically significant difference compared to the injection only group (Po0.01). C, control, electrodes were not applied to the liver; E, electrodes were applied, but pulses were not delivered. Figure 6 Effect of time interval between naked pDNA injection and electroporation on transgene expression. Naked pDNA was injected into the tail vein at a dose of 25 mg/mouse, and electric pulses (50-500 V/cm, 5 ms/pulse, 12 pulses, 4 Hz) were applied to the left lateral lobe of the liver at different intervals. Results are expressed as the mean7s.d. of at least three mice.
Hepatocyte-targeted gene transfer by vascular pDNA M Sakai et al Cellular distribution of radioactivity and transgene expression in mouse liver after injection of naked pDNA followed by electroporation Naked pDNA is extensively taken up by liver NPC via mechanism(s) like scavenger receptors. 18, 21 In the nonelectroporated lobes of the liver, 32 P-radioactivity preferentially distributed to NPC rather than hepatocytes (parenchymal cells, PC) (Figure 9a ). NPC uptake was about three-fold greater than PC uptake on a cell number basis, with a PC/NPC ratio of 0.35. The PC/NPC ratio increased in the electroporated lobe to 0.78, indicating that the distribution of pDNA shifted from NPC to PC by electroporation.
As shown in Figure 4 , transgene expression was very high in the electroporated lobe. Separation of the cells in the lobe clearly demonstrated that the expression in PC was significantly (Po0.01) greater than that in NPC (Figure 9b) . Figure 10b and c shows typical liver tissues receiving an intravenous injection of naked b-galactosidase-expressing pDNA followed by electroporation. For comparison, naked pDNA was directly injected into the left lateral lobe of the liver (Figure 10a ), which resulted in a very localized distribution of b-galactosidase-positive cells near the injection site (arrow). Greater numbers of hepatocytes in a large area around the site of electroporation were transfected by intravenous naked pDNA followed by electroporation (Figure 10b and c) .
Analysis of the number of cells expressing transgene product
To quantitatively evaluate the number of b-galactosidase-positive cells, we isolated hepatocytes from the left lateral lobe of the liver after administration of b-galactosidase-expressing pDNA to mice (Figure 10d ). 
The number of hepatocytes expressing b-galactosidase using vascularly administered naked pDNA followed by electroporation was significantly (Po0.01) and about 25-fold greater than that obtained by local injection of naked pDNA.
Discussion
Naked pDNA injection is the simplest method of the nonviral gene delivery approaches. However, no significant gene expression can be detected in any tissue when naked pDNA is intravenously injected by a normal, conventional technique because of its rapid degradation and low membrane permeability. Therefore, pDNA needs to be protected from nuclease-mediated degradation by complex formation with a vector such as cationic polymer or cationic liposome. 1 Cationic vectors can increase transfection efficiency by pDNA, but the expression level seems to be still low as far as therapeutic applications are concerned. As a different challenge involving in vivo gene transfer, electroporation has been applied to various tissues after local injection of naked pDNA, and great improvements in transgene expression have been reported. 9 However, direct tissue injection of pDNA has the disadvantage of the limited distribution of transfected cells, 16, 22 which would greatly restrict the efficacy of gene replacement therapy of intracellular protein. 23 These two different approaches, that is, pDNA delivery via the intravascular route and in vivo electroporation, could be used to achieve significant transgene expression in a large number of target cells. In a pioneer work by Liu and Huang, 17 this approach was found to be effective as far as achieving transgene expression in a greater number of liver cells was concerned. However, it was not clear how electroporation alters the distribution of pDNA within the liver. Transgene expression occurs only in the cells that take up intact pDNA into the cytoplasm. Therefore, in the present study, we focused on the changes in the distribution of pDNA and examined the option involving liver-targeted gene transfer by injecting naked or hepatocyte-targeted pDNA followed by electroporation to the organ.
As hepatocytes uniquely express asialoglycoprotein receptors on their sinusoidal surface, asialoglycoproteins or galactosylated polymers have been used to deliver a variety of pharmaceutical agents ranging from anticancer drugs to genes. Attempts to deliver pDNA to hepatocytes by conjugating or mixing it with galactose-containing vectors, however, sometimes resulted in failure because of problems in tissue distribution. We have been trying to overcome these problems by controlling the physicochemical properties of the pDNA/galactosylated vector complex. 2, 3, 20 In these studies, we successfully delivered pDNA to the liver, especially to hepatocytes, in amounts up to about 60% of the injected dose of pDNA. Although the pDNA complex taken up by asialoglycoprotein receptor-mediated endocytosis undergoes lysosomal degradation, a fraction is believed to be released from the endosome/lysosome pathway into the cytoplasm, then being transported into the nucleus. Some structural features have been introduced onto vectors to increase gene transfer by facilitating the release of pDNA into the cytoplasm. They are fusogenic peptides, which create pores on the plasma and/or endosomal membrane, 2, 24 and polymers having buffering capacity like PEI. 25 In the present study, pDNA/galactosylated vector complexes showed greater transgene expression in the liver than naked pDNA. Of the complexes used, Gal-PEI was superior to Gal-PLL in terms of transfection efficiency to mouse liver, reflecting the buffering ability of PEI. Electroporation of a set of fixed parameters (250 V/cm, 5 ms/pulse, 12 pulses, 4 Hz) increased the expression in the electroporated lobe of the liver after intravenous injection of both pDNA/Gal-PLL and pDNA/Gal-PEI complexes. As the tissue distribution profile of 32 P-pDNA was hardly altered by electroporation (Figure 2) , the enhanced expression would be mediated by changes in the intrahepatic and/or intracellular distribution of pDNA. Assuming that electroporation creates pores on biological membranes, 9 it is reasonable to accept that it can increase the amount of pDNA delivered to the cytoplasm prior to degradation. The pDNA/galactosylated vector complex is believed to bind to cell-surface receptors, captured in endosomes and then transported into lysosomes where it is degraded. In the present study, electric pulses were applied to a mouse at 30 s after injection of the pDNA/ vector complex. However, the interval between the injection and electroporation may affect the results. The application of electric pulses at later times such as 5 or 10 min after injection did not increase the expression in the liver (data not shown). Furthermore, an increase in the amount of Gal-PLL or Gal-PEI in each complex Hepatocyte-targeted gene transfer by vascular pDNA M Sakai et al reduced the enhancement ratio produced by electroporation ( Figure 3 ). These results, together with those obtained using naked pDNA, suggest that the polymers disturb to a certain degree the electroporation-mediated enhancement in transgene expression, although galactosylated vector-mediated gene transfer could be improved by in vivo electroporation. Different parameters involving the number, duration and electric field of electric pulses hardly improved the electroporation-mediated transgene expression by pDNA/vector complex (data not shown).
The results of transgene expression in HepG2 cells strongly support the hypothesis that the free form of pDNA is more effective than its complexed form for transgene expression once it enters into the cytoplasm of cells.
In order to achieve liver-directed gene transfer, naked pDNA has been administered by various methods, including local tissue injection, 16 electroporation after local injection, 12, 13 intraportal injection in a hypertonic solution, 26, 27 gene gun, 28 and large-volume injection at a high velocity. 7, 8 In some cases, transfection efficiency by naked pDNA exceeds that by the pDNA/vector complex. Electroporation generally increases the level of transgene expression up to 1000-fold, but the distribution of cells expressing the transgene product is still limited to around the injection site. It is expected that, when pDNA is injected into the vasculature instead of into the tissue parenchyma, it will be delivered to the vicinity of a large number of cells. Rapid injection of naked pDNA solution into the vasculature has resulted in high transgene expression in a large number of myotubes. 29 Furthermore, intraportal injection of pDNA in a hypertonic solution achieved widespread distribution of transfected cells throughout the liver. 26, 27 These approaches, however, need to be studied to investigate the tissue damage induced by the procedures. Although electroporation might also induce tissue damage after its application onto the liver surface, we observed very little GPT leakage and little change in appearance, indicating that the conditions for electroporation used in this study do not result in severe tissue damage. This is marked contrast to the large volume injection of pDNA solution at high-velocity, which induced the leakage of enormous amounts of liver transaminases over a short period after injection. 30 When intravenously injected, naked pDNA undergoes rapid degradation by nuclease and clearance by Kupffer cells, splenic macrophages, and sinusoidal endothelial cells in the liver. 18, 19 No detectable transgene expression was observed in the liver. It is suggested that when electric pulses are applied to the surface of the liver, intravenously injected naked pDNA will pass through the discontinuous endothelium of the liver vascularture, reach the surface of hepatocytes, and then enter the cytoplasm through the pores created by electroporation. The application of electric pulses at different intervals clearly demonstrated that the electroporation-induced gene transfer is mediated by pDNA present in the circulation ( Figure 6 ). There was a good correlation between the plasma concentration of undegraded pDNA and transgene expression (correlation coefficient: r 2 ¼ 0.97). These findings suggest that any approach to increase the plasma retention, not to increase delivery to the liver, of pDNA could further improve electroporation-mediated gene transfer to the organ.
pDNA is significantly taken up by liver NPC due to its strong negative charge. 18, 19 Electroporation did alter the distribution of 32 P-pDNA between hepatocytes (PC) and NPC: the distribution ratio of naked 32 P-pDNA to PC was greater in the electroporated lobe compared with that in the non-electroporated lobe (Figure 9a ). These results suggest that electroporation selectively increases the delivery of pDNA to PC. Anatomical features do not explain the selectivity because PC are localized underneath the lining of the sinusoidal endothelial cells that should have an initial contact with vascularly injected pDNA. Canatella and Prausnitz 31 experimentally and theoretically derived an equation to predict the effects of electroporation on the uptake of solute by cells and their viability. According to this equation, the cell volume is a major factor determining the number of solute (eg pDNA) molecules delivered to the cell; liver PC, or hepatocytes, are much larger in size than liver NPC. Such a difference in size would explain the selective increase in the uptake of pDNA by hepatocytes. Transgene expression correlated well with the amount of pDNA delivered to each type of cells, and hepatocytes had a greater amount of expression than NPC. The efficiency of expression would depend on the cell type, and macrophages such as Kupffer cells undergo transfection with difficulty, which would broaden the difference between hepatocytes and other cells in terms of transgene expression.
In the present study, we successfully demonstrated that the total number of transfected cells was much greater in the liver of mice given an intravenous injection of naked pDNA followed by electroporation than in animals given a local injection of pDNA into the liver (Figure 10) . A further increase in this number could be achieved by modification of the size and shape of the electrodes, because the cells between or around them were the major cells transfected.
In conclusion, a more than 200 000-fold increase in transgene expression in the liver was achieved by in vivo electroporation after intravenous injection of naked pDNA. pDNA in blood circulation is delivered to the inside of the cells, leading to transgene expression. Although the galactosylated vector is effective in delivering pDNA to hepatocytes through the receptormediated process, the vector itself can be an obstacle in the electroporation-mediated increase in transgene expression. These results indicate that the application of electroporation to vascularly administered naked pDNA is a useful gene transfer method for reaching a large number of hepatocytes, which is a key factor in determining the therapeutic efficacy of the in vivo gene therapy approach to treating hepatic diseases lacking any intracellular protein, liver cancer, viral hepatitis and allograft rejection. Clinical application of this approach may be achieved in combination with abdominal operation, or by the development of endoscope-type electrodes.
Materials and methods

Chemicals
[a-32 P]dCTP was obtained from Amersham (Tokyo, Japan). Poly(L-lysine) (PLL: average molecular weight 29 000) and branched polyethyleneimine (PEI: 70 000) 3, 18 by covalently binding 2-imino-2-methoxyethyl 1-thiogalactoside to each polymer. The numbers of galactose molecules per polymer were: 44 for Gal-PLL and 60 for Gal-PEI.
Animals
Male ddY mice (5 weeks old) were purchased from Japan SLC Inc. (Shizuoka, Japan) and maintained on a standard food and water diet and housed under conventional conditions. All animal experiments were carried out in accordance with the Guidelines for Animal Experiments of Kyoto University.
Preparation of pDNA pDNA encoding firefly luciferase cDNA under the control of CMV-IE promoter was prepared as previously reported.
2 pCMV.SPORT-bgal was purchased from GibcoBRL (GibcoBRL, Carlsbad, CA, USA). pDNA was amplified in DH5a, isolated and purified using a QIAGEN Plasmid Giga Kit (QIAGEN, Hilden, Germany). The purity of the pDNA was confirmed by 1% agarose gel electrophoresis followed by ethidium bromide staining. The pDNA concentration was measured by UV absorption at 260 nm. pDNA was labeled with [a- Formation of pDNA complex pDNA complex was prepared in 5% dextrose solution. Various amounts of Gal-PLL or Gal-PEI were added to pDNA, and the mixture was tapped and then left for over 30 min at room temperature. The N/P ratio, the ratio of the concentration of total nitrogen atoms in the polymer to the phosphate group (P) in pDNA, was used as an index of formation. Based on the complex formation and previous studies, N/P ratios were set at 1.2 and 2.4 for the Gal-PLL complex, and 3 and 7 for the Gal-PEI complex.
Electrodes and electric pulse delivery
Electric pulses were delivered to the liver by a pair of 1-cm 2 forceps-type electrodes connected to a rectangular direct current generator (CUY21, Nepagene, Chiba, Japan).
Electric gene delivery after systemic administration of pDNA complex
Mice were anesthetized by intraperitoneal injection of sodium pentobarbital (50 mg/kg). A midline incision was made on the abdomen and the liver was exposed. Then 5% dextrose solution of naked pDNA or pDNA complex was injected into the tail vein at a fixed dose of 25 mg pDNA/mouse. Unless otherwise indicated, electric pulses were delivered to the left lateral lobe of the liver through the electrodes at 30 s after injection. The electric pulse parameters were: 5 ms/pulse, 12 pulses, 4 Hz, and variable electric field from 50 to 500 V/cm. The incision was closed with metal clips or sutured. At 6 h after pDNA injection, the mice were killed and the liver was excised and divided into two parts: the electroporated lobe (the left lateral lobe) and the other lobes. The liver lobes were homogenized with a five-fold excess of lysis buffer (0.05% Triton X-100, 2 mM EDTA, 0.1 M Tris, pH 7.8). Then the homogenates were subjected to three cycles of freezing and thawing, and centrifuged at 10 000 g for 8 min at 41C. The supernatant was used for the measurement of luciferase assay. The protein content of each supernatant was also determined using a Protein Quantification Kit (Dojindo Molecular Technologies, Kumamoto, Japan). The GPT level in plasma was measured using a GPT-UV test kit (Wako, Osaka, Japan).
In vivo distribution experiment 32 P-pDNA was added to unlabeled pDNA to give an injection dose of 25 mg pDNA/mouse. Each mouse was injected with 32 P-pDNA or its complex in 5% dextrose solution. Then, electric pulses of 250 V/cm, 5 ms/pulse, 12 pulses, 4 Hz were applied to the left lateral lobe of the liver at 30 s after injection. At 1, 5, 10 and 30 min after injection, groups of three mice each were anesthetized with ether and blood was collected from the vena cava and plasma samples were obtained by centrifugation. The liver, kidney, spleen, lung and heart were excised, rinsed with saline and weighed. These organs were homogenized with 0.05% Triton X-100 solution. Each sample was dissolved in Soluene-350 (Packard, Netherlands), then scintillation medium (Clear-sol I, Nacalai Tesque, Kyoto, Japan) was added and the 32 P-radioactivity was counted in an LSC-5000 liquid scintillation counter (Beckman, Tokyo, Japan). Radioactivity derived from the plasma in each tissue was corrected for as previously reported. 2 Isolation of liver PC and NPC pDNA or 32 P-pDNA was injected and electric pulses were applied as above. At 10 min (for radioactivity measurement) or 6 h (for luciferase assay) after injection, liver cells were separated into hepatocytes (PC) and NPC as reported previously. 18 In brief, the liver was perfused with a buffer containing collagenase. The dispersed cells were separated into PC and NPC fractions by differential centrifugation. These cell fractions were subjected to 32 P-radioactivity measurement or luciferase assay.
Stability of pDNA in plasma after intravenous injection
Mice received 25 mg pDNA into the tail vein. At indicated time points, 500 ml blood was collected from the vena cava. pDNA was extracted and electrophoresed as reported previously. 19 The amount of pDNA was evaluated by computerized densitometry.
Assessment of transgene-positive cells by X-gal staining of whole liver Naked pCMV.SPORT-bgal (25 mg/mouse) was administered as described above. The liver was removed at 24 h after injection, then placed in a fixing solution (4% paraformaldehyde, 0.1 M NaH 2 PO 4 /Na 2 HPO 4 , pH 7.3, 2 mM MgCl 2 , 0.01% sodium deoxycholate, and 0.02% IGEPAL C-630 (Sigma)) for 60 min at 41C, and rinsed three times with a wash buffer (0.1 M NaH 2 PO 4 / Na 2 HPO 4 , pH 7.3, 2 mM MgCl 2 , 0.01% sodium deoxycholate, and 0.02% IGEPAL C-630). b-Galactosidase activity was detected by immersing the liver in 5-bromoHepatocyte-targeted gene transfer by vascular pDNA M Sakai et al 4-chloro-3-indolyl-b-galactopyranoside (X-gal, Sigma) staining solution (1 mg/ml X-gal, 5 mM ferricyanide and 5 mM ferrocyanide at pH 7.3-7.6 in the wash buffer) for 16-24 h at 371C. For comparison, the same amount of pDNA in 20 ml 5% dextrose solution was injected directly into the lobe and the X-gal staining was performed in a similar manner.
Quantification of b-galactosidase-expressing hepatocytes
At 48 h after administration of pCMV.SPORT-bgal, hepatocytes were isolated as above from the left lateral lobe of the liver, the lobe receiving the electric pulses after intravenous injection of naked pDNA (i.v. injection+EP group) or an injection of naked pDNA (direct injection group). The hepatocytes isolated and supplemented with William medium E containing 10% fetal bovine serum were seeded into culture plates. After 12-h incubation, the hepatocytes were washed, fixed with 0.25% glutaraldehyde for 20 min at 41C, then stained with X-gal solution (1 mg/ml in phosphate-buffered saline, pH 7.4) for 16-24 h at 371C. More than 100 individual cells per sample were observed under a microscope, and the number of blue cells, that is, b-galactosidase-expressing cells, was counted. Results are expressed as the percentage of b-galactosidaseexpressing hepatocytes in the left lateral lobe of the liver.
Transfection to HepG2 cells
HepG2 cells, a human hepatoma cell line, were seeded to 2 Â 10 6 cells in Dulbecco's minimum essential medium/ 10% fetal bovine serum in six-well plates for 24 h prior to transfection. Naked pDNA or pDNA/Gal-PLL was added to the cells and electric pulses (95 V, 5 ms/pulse, 12 pulses, 10 Hz) were delivered to the cells through an electrode for cultured cells. The luciferase activity was assayed at 24 h after transfection.
Statistical analysis
Data were statistically analyzed by Student's t-test.
